• ABOUT US
    ABOUT US OUR TEAM
  • SCIENCE
  • PIPELINE
  • THERAPEUTIC AREAS
  • NEWS AND MEDIA
  • CAREERS
  • EN CN
Home NEWS AND MEDIA

NEWS AND MEDIA

  • Mar 2025

    NeuExcell Therapeutics Initiates First-in-Human Clinical Trial of NXL-001 to Treat Alzheimer's Disease

    Learn more
  • May 2024

    NeuExcell will present its stroke NHP data at the ASGCT Annual Meeting on May 10, 2024 10,

    Learn more
  • Mar 2024

    NeuExcell Therapeutics Announces Successful Dosing of First Patient by NeuroD1 Gene Therapy

    Learn more
  • Dec 2023

    NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA

    Learn more
  • May 2023

    NeuExcell Therapeutics Raises $15+ Million Pre-A+ Round

    Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.

    Learn more
123
  • Philadelphia, USA

  • Shanghai, China

  • Suzhou, China

Collaborate with us!
Contact us: info@neuexcell.com
© 2025 NeuExcell Therapeutics Inc
Design By Sumaart